Multiple myeloma-associated drug resistance : targeting the Notch pathway
S. Garavelli(University of Milan), Raffaella Chiaramonte(University of Milan), Katia Todoerti(Fondazione IRCCS Istituto Nazionale dei Tumori), Antonino Neri(University of Milan), Elisa Lazzari(University of Trieste), Alessandro Paoli(University of Milan), S. Galletti, A. Moschini, Natalia Platonova(University of Milan), M. Colombo(Human Technopole)
Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
January 1, 2015
Cited by 1
Related Papers
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
|Leukemia|2009|877
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
|Blood|2015|216
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma
|Nature Communications|2017|142
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
|Blood|2020|139
Autoimmune cytopenias in chronic lymphocytic leukemia
|American Journal of Hematology|2014|119